Why Subscribe?

More than one reader: Corporate license details.

Individuals will get:

  • My weekly Edge column. TR anticipates trends and spots patterns ahead of the pack to give you an informational advantage. The Edge runs Mondays. Sample headlines herehere, and here.
  • My Frontpoints week in review. TR makes sure you don’t miss the most important news, deals, and shenanigans–with a dash of context and commentary. Frontpoints runs Fridays. Sample headlines here, here, and here.
  • In-depth reports on the scientific, medical, financial & political aspects of industry, from an integrative thinker with 15 years covering the industry. Reports run regularly. Sample headlines here, here, and here.
  • No ads. I won’t sell your data, and I won’t waste your time.
  • Elite readers. Join a community of biotech’s leading thinkers and doers.

Over time, TR will help you find your next partner, next investment opportunity, or next job.

Subscribe today

Corporate site license

Companies can get a 10% discount off the regular rate of $149 per person per year by purchasing a group of subscriptions. Get one easy payment and one shared company login.

Pricing:

Company sizeEstimated # of readersPrice
50 employees or less5$670
50-500 employees15$2,000
500-5,000 employees35$4,700
5000+ employees100$13,400

Individual subscriptions cannot be shared; that is a copyright violation. By purchasing a corporate license, you obtain the right to share Timmerman Report content internally. You also can request a free PDF of a story you’d like to post on your internal website.

To purchase a bulk subscription, e-mail me at luke@timmermanreport.com.